Delivery Order 75N95021D00014-75N95023F00001
Award Date
5/1/21
Potential Completion Date
4/30/26
Potential Value
$47K
Federal Agency
National Institute on Drug Abuse
Awardee
The Bizzell Group LLC
Ultimate Awardee
Not listed
PSC Category
R708 - Support- Management: Public Relations
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Bowie, MD 20720, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $56,242.49 delivery order contract to The Bizzell Group LLC, a self-certified small disadvantaged business and HUBZone firm, to provide logistics, communications and clinical study auxiliary support services for the agency's Division of Therapeutics and Medical Consequences program from May 1, 2021 through April 30, 2026. The contract has no set-aside designation. Services will be...
The National Institute on Drug Abuse, a division of the Department of Health and Human Services, awarded a $22,571.04 firm fixed price delivery order against its Logistics, Communications and Clinical Study Auxiliary Support indefinite delivery/indefinite quantity contract to The Bizzell Group LLC. This Task Order 3 calls for manuscript, mail merge, and payments to Data and Safety Monitoring Board member consultants to support the division's clinical study efforts. As an 8(a) HUBZone certified...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $36,545.35 firm fixed price delivery order to The Bizzell Group LLC for FY23 global data database subscription services. As a HUBZone certified small business, The Bizzell Group will provide logistics, communications, and clinical study support involving therapeutics and drug abuse research. The order was awarded on May 1, 2023 with an anticipated completion date of April 30,...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $54,177.64 cost-no-fee delivery order to The Bizzell Group LLC under its indefinite-delivery/indefinite-quantity contract number 75N95021D00014 to provide Global Clinical Program adherence site visits. As a HUBZone-certified small business, The Bizzell Group will conduct monitoring at locations supporting the Division of Therapeutics and Medical Consequences' clinical studies...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $34,271 firm fixed price delivery order to The Bizzell Group LLC for FY21 Task Order 1 under the Integrity/Cortellis Discovery Intelligence subscription. As a HUBZone certified small business, The Bizzell Group will provide logistics, communications, and clinical study support services to the Division of Therapeutics and Medical Consequences via its Integrity/Cortellis Discovery...
The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $33,075.14 Delivery Order contract to The Bizzell Group LLC, a minority-owned, Small Disadvantaged, HUBZone certified small business, to provide Logistics, Communications, and Clinical Study Auxiliary Support for the Division of Therapeutics and Medical Consequences. The period of performance is from May 1, 2021 to April 30, 2026. This award is not associated with a set-aside program. The Bizzell Group LLC holds multiple...
This is a firm fixed-price delivery order awarded by the Department of Health and Human Services' National Institutes of Health, National Institute on Drug Abuse, to The Bizzell Group LLC, a U.S. Small Business Administration (SBA) certified HUBZone firm. The contract provides $40,046.94 in logistics, communications, and clinical study auxiliary support for the Division of Therapeutics and Medical Consequences, with a period of performance from May 1, 2021 to April 30, 2026. The Bizzell Group, a...
This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency, to The Bizzell Group LLC, a U.S. Small Business Administration (SBA) certified HUBZone, minority-owned firm. The $64,514.35 delivery order contract is for clinical trial safety toxicology consulting, logistics, communications, and clinical study auxiliary support for NIDA's Division of Therapeutics and Medical Consequences. The award is not associated with a larger contract vehicle and...
This is a $8,329,313.99 cost-plus-fixed-fee definitive contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to The Bizzell Group LLC, a U.S. Small Business Administration (SBA) certified HUBZone, minority-owned firm. The contract supports logistical support services for the National Institute of Mental Health (NIMH), a major program within NIH. It is a competitive 8(a) set-aside contract with a performance...
This is a delivery order contract for logistics, communications, and clinical study auxiliary support services for the Division of Therapeutics and Medical Consequences at the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The prime contractor is The Bizzell Group LLC, a U.S. Small Business Administration (SBA) certified HUBZone firm that is Minority-owned and self-certified as a Small...